http://localhost:8080/xmlui/handle/123456789/8951 1 - 210 2026-04-14T20:40:53Z http://localhost:8080/xmlui/handle/123456789/9027 Title: Corrigendum to Evolution of estimated glomerular filtration rate in HIV/HCVcoinfected patients who received directacting antivirals: A multicenter retrospective study [J Microbiol Immunol Infect 56 (2023) 718-728] Authors: Tsai, Ching-Yen; Chen, Guan-Jhou; Tsai, Chin-Shiang; dkk. 2024-02-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9026 Title: Corrigendum to <‘Efficacy and safety of anti-interleukin-5 therapy in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized, controlled trials’>[J Microbiol Immunol Infect 55 (1) (2022) 26-35] Authors: Lan, Shao-Huan; Lai, Chih-Cheng; Chang, Shen-Peng; dkk. 2024-02-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9025 Title: Pneumonia and brain abscess likely due to Cladophialophora bantiana in a patient with systemic lupus erythematosus in Taiwan 2024-02-01T00:00:00Z http://localhost:8080/xmlui/handle/123456789/9024 Title: Under-utilization of statins among people with HIV who were aged 40 years or older Authors: Wu, Pei-Ying; Sun, Hsin-Yun; Huang, Yu-Shan; dkk. Abstract: From June 2022 to April 2023, 1629 HIV-positive participants were assessed for the risk of atherosclerotic cardiovascular disease (ASCVD). The 10-year ASCVD risk of <5 %, 5 % to <7.5 %, 7.5 % to <20 % and 20 % were 59.9 %, 14.4 %, 20.7 % and 5.0 %, respectively; 440 (27.0 %) participants met the criteria for statin therapy, but only 171 (38.8 %) were prescribed statins. 2024-02-01T00:00:00Z